From cryptic chromosomal lesions to pathologically relevant genes: Integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype-Reference-Cited by-同舟云学术

From cryptic chromosomal lesions to pathologically relevant genes: Integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype

Published:2012-01-17 Issue:5 Volume:51 Page:419-428
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Merkerova Michaela Dostalova,Bystricka Dagmar,Belickova Monika,Krejcik Zdenek,Zemanova Zuzana,Polak Jaroslav,Hajkova Hana,Brezinova Jana,Michalova Kyra,Cermak Jaroslav

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference24 articles.

1. Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia;Bajaj;Mol Cytogenet,2001

2. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes;Bakshi;J Cell Physiol,2010

3. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;N Engl J Med,2011

4. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia;Cermák;Leuk Res,2005

5. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: A European leukemianet study;Cilloni;J Clin Oncol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms;Cancer Genetics;2018-12

2. Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes;Cells;2018-09-14

3. Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome;Modern Pathology;2017-12-15

4. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes;Scientific Reports;2017-09-04

5. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes;PLOS ONE;2016-10-14